Handbook of Clinical medicine

GCS, ophthalmop legia/visual fi eld defect, especially if there is a known tumour (may present like suba rachnoid haem- orrhage). : Urgent steroids (hydrocortisone 100mg IV) and meticulous fl uid balance ± cabergoline (dopamine agonist, if prolactinoma) ± surgery; fi nd the cause, eg a predisposition to thrombosis, from antiphospholipid syndrome. Craniopharyngioma Not strictly a pituitary tumour: it originates from Rathk e’s pouch so is situated between the pituitary and 3rd ventricle fl oor. They are rare, but are the commonest childhood intracranial tumour. Over 50% present in childhood with growth failure; adults may present with amenorrhoea, libido, hypothalamic symptoms (eg DI, hyperphagia, sleep disturbance) or tumour mass eff ect. Tests: CT/ MRI (calcifi cation in 50%, may also be seen on skull x-ray). Treatment: Surgery ± post-op radiation; test pituitary function post-op. Table 5.4 Frequency of hormones secreted by pituitary adenomas based on immunohistochemistry Hormone % Hormone % PRL only (prolactinoma) 35% ACTH (Cushing’s disease) 7% GH only (acromegaly) 20% LH/FSH/TSH ≥1%* PRL and GH 7% No obvious hormone 30% *Sensitive methods of TSH measurement have improved recognition of TSH-secreting tumours. These are now more frequently found at microadenoma stage, medially loca ted, and without associated hormone hypersecretion. In
